-
Cycloheximide Workflows for Protein Turnover Studies
2026-09-07
Use Cycloheximide as a rapid translational elongation inhibitor to separate protein synthesis from degradation, strengthen apoptosis assays, and interrogate stress-responsive pathways. This workflow-oriented guide connects CHX chase experiments with the Parkin–Ku70 mechanism reported in lens epithelial cells while emphasizing controls, interpretation, and reproducibility.
-
Z-VAD-FMK Workflows for Apoptosis Studies
2026-09-07
Build cleaner apoptosis experiments with Z-VAD-FMK by separating caspase-dependent death from ferroptosis, mitophagy, and other stress responses. This workflow translates tendon stem cell findings into practical controls for immune-cell, cancer research, and mechanistic signaling assays.
-
Necrostatin-1: RIP1 Inhibitor Assay Guide
2026-09-05
A scenario-based guide to using Necrostatin-1 as a RIP1 kinase inhibitor in necroptosis, viability, and cytotoxicity workflows. It explains how SKU A4213 supports practical assay design, solvent handling, interpretation of EC50 and IC50 values, and vendor selection.
-
Red Blood Cell Lysis Buffer for Bone Research
2026-09-04
Use selective erythrocyte removal to improve mammalian blood sample preparation for flow cytometry, molecular assays, and cell culture. This workflow guide connects practical sample cleanup with the RUNX2–AMPK osteoblast findings reported in MC3T3-E1 cells, while clearly separating established evidence from assay-development recommendations.
-
EZ Cap Cy5 Firefly Luciferase mRNA: A Delivery Compass
2026-09-04
EZ Cap Cy5 Firefly Luciferase mRNA converts delivery, intracellular trafficking, and translation into complementary readouts. This article presents a practical framework for using its Cy5 and luciferase signals to diagnose formulation performance rather than merely record endpoint expression.
-
Genistein for Mechanotransduction Assays
2026-09-04
Use Genistein to separate growth-factor kinase signaling from cytoskeleton-dependent responses to mechanical stress. This workflow combines dose-defined signaling perturbation, autophagy measurements, proliferation readouts, and practical controls for cancer biology and mechanobiology studies.
-
PTX3–TLR4/NF-κB Axis in Glucocorticoid ONFH
2026-09-03
The reference study identifies a protective PTX3–TLR4/NF-κB–FGF21 signaling axis in glucocorticoid-induced osteonecrosis of the femoral head (ONFH). Its combination of patient evidence, cell models, Ptx3-deficient mice, pathway blockade, and downstream rescue experiments supports PTX3 and FGF21 regulation as mechanistically connected points for future ONFH research.
-
Axitinib (AG 013736) Assay Guide
2026-09-02
Learn how Axitinib (AG 013736), SKU A8370, can support reproducible VEGF-pathway studies while avoiding common errors in solubility, viability interpretation, and vendor selection. This scenario-based guide connects product benchmarks with practical assay design and evidence from cancer-response methodology.
-
Bufalin Workflow for TNBC Mechanism Studies
2026-09-02
Build a practical Bufalin workflow that connects viability and apoptosis readouts with STK33 target engagement, protein degradation, and organoid validation. The guide also covers formulation, assay controls, and troubleshooting for triple-negative breast cancer research and related oncology models.
-
gamma-Glu-Cys Workflows for Glutathione Research
2026-09-01
Use gamma-Glu-Cys as a defined substrate for glutathione synthetase enzyme assays, pathway studies, and controlled peptide workflows. Its value is greatest when researchers separate reproducible substrate testing from the complex medium effects revealed in Bacillus fermentation research.
-
Full-Length αvβ3 Integrin Structures by Cryo-EM
2026-09-01
A 2026 cryo-EM study resolves full-length human αvβ3 integrin in six apo and five ligand-bound conformations, including five previously uncharacterized states. The structures support a continuum model of integrin activation and clarify how CWHM-12 can stabilize distinct inhibited conformations, providing a framework for more selective inhibitor design.
-
Purmorphamine: An Assay-First Hedgehog Guide
2026-08-31
Purmorphamine is a Smoothened agonist for dissecting Hedgehog signaling in osteogenic, neural, and sensory models. This assay-first guide connects molecular pharmacology with the cross-species Smo evidence that determines how experiments should be designed and interpreted.
-
Tiamulin: Metabolism-Aware Assay Design
2026-08-31
Tiamulin (Thiamutilin) is more than a pleuromutilin antibiotic: its species-dependent metabolism directly affects residue testing, pharmacodynamic interpretation, and translational assay design. This evidence-led guide connects ribosomal pharmacology with practical veterinary and inflammation research workflows.
-
Z-LEHD-FMK: Caspase-9 Inhibition Workflows
2026-08-30
Z-LEHD-FMK helps separate mitochondria-mediated apoptosis from upstream stress and extrinsic death signaling in cell, cancer, and injury models. This practical guide covers assay design, pathway controls, formulation, and troubleshooting, with a focused application to SARS-CoV-2 ORF3a variant research.
-
KRas Transfer by Tunneling Nanotubes
2026-08-29
The reference study shows that tunneling nanotubes can transfer mutant KRas between tumor cells, converting previously different cells into a mechanically altered, more invasive population. By combining confocal fluorescence imaging, optical tweezers, and gene interference, the authors connect oncogenic protein transfer with reduced membrane tension, faster phospholipid flow, and tumor-cell migration.